Live feed
·
INSIDERFilingvia Quantisnow
BioAge Labs Inc. logo

Director Enright Patrick G converted options into 1,310,589 shares and bought $7,200,000 worth of shares (400,000 units at $18.00) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight
Quantisnow market dataNASDAQ
BioAge Labs Inc. logo
BIOA
BioAge Labs Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2024
Get push alerts for BIOA

Follow BIOA and get a push notification the moment its next story breaks.

Full BIOA profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIOA (BioAge Labs Inc.) and more on Quantisnow.